Disc Medicine (IRON) Competitors

Elanco Animal Health (NYSE:ELAN) and Disc Medicine (NASDAQ:IRON) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, community ranking, profitability, earnings and risk.

Does the media refer more to ELAN or IRON?

In the previous week, Elanco Animal Health had 11 more articles in the media than Disc Medicine. MarketBeat recorded 17 mentions for Elanco Animal Health and 6 mentions for Disc Medicine. Elanco Animal Health's average media sentiment score of 1.34 beat Disc Medicine's score of 0.65 indicating that Elanco Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elanco Animal Health	14 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Disc Medicine	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders hold more shares of ELAN or IRON?

97.5% of Elanco Animal Health shares are owned by institutional investors. Comparatively, 83.7% of Disc Medicine shares are owned by institutional investors. 0.9% of Elanco Animal Health shares are owned by insiders. Comparatively, 4.2% of Disc Medicine shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Is ELAN or IRON more profitable?

Elanco Animal Health has a net margin of 4.60% compared to Disc Medicine's net margin of 0.00%. Elanco Animal Health's return on equity of 6.78% beat Disc Medicine's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	4.60%	6.78%	3.03%
Disc Medicine	N/A	-25.24%	-23.96%

Which has more volatility and risk, ELAN or IRON?

Elanco Animal Health has a beta of 1.49, indicating that its share price is 49% more volatile than the S&P 500. Comparatively, Disc Medicine has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500.

Do analysts prefer ELAN or IRON?

Elanco Animal Health presently has a consensus target price of $15.17, suggesting a potential upside of 20.13%. Disc Medicine has a consensus target price of $98.80, suggesting a potential upside of 101.39%. Given Disc Medicine's stronger consensus rating and higher probable upside, analysts plainly believe Disc Medicine is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43
Disc Medicine	0 Sell rating(s)	0 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	3.09

Does the MarketBeat Community favor ELAN or IRON?

Elanco Animal Health received 85 more outperform votes than Disc Medicine when rated by MarketBeat users. However, 86.76% of users gave Disc Medicine an outperform vote while only 54.96% of users gave Elanco Animal Health an outperform vote.

Company	Underperform	Outperform
Elanco Animal Health	Outperform Votes 144 54.96%	Underperform Votes 118 45.04%
Disc Medicine	Outperform Votes 59 86.76%	Underperform Votes 9 13.24%

Which has preferable valuation and earnings, ELAN or IRON?

Disc Medicine has lower revenue, but higher earnings than Elanco Animal Health. Disc Medicine is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$4.43B	1.42	-$1.23B	$0.74	17.06
Disc Medicine	N/A	N/A	-$76.43M	-$3.92	-12.52

Summary

Elanco Animal Health beats Disc Medicine on 11 of the 18 factors compared between the two stocks.